-
1
-
-
0027434883
-
Benefits and adverse effects of weight loss: Observations from the Framingham Study
-
Higgins M, D'Agostino R, Kannel W, Cobb J, Pinsky J: Benefits and adverse effects of weight loss: observations from the Framingham Study Ann Intern Med 119:758-763, 1993
-
(1993)
Ann Intern Med
, vol.119
, pp. 758-763
-
-
Higgins, M.1
D'Agostino, R.2
Kannel, W.3
Cobb, J.4
Pinsky, J.5
-
2
-
-
0029966681
-
Weight and non-insulin-dependent diabetes mellitus
-
Pi-Sunyer F: Weight and non-insulin-dependent diabetes mellitus. Am J Clin Nutr 63 (Suppl. 3):426S-429S, 1996
-
(1996)
Am J Clin Nutr
, vol.63
, Issue.SUPPL. 3
-
-
Pi-Sunyer, F.1
-
3
-
-
0028917432
-
Weight gain as a risk factor for clinical diabetes mellitus in women
-
Colditz G, Willett W, Rotnitzky A, Manson J: Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481-486, 1995
-
(1995)
Ann Intern Med
, vol.122
, pp. 481-486
-
-
Colditz, G.1
Willett, W.2
Rotnitzky, A.3
Manson, J.4
-
4
-
-
0027966932
-
Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men
-
Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC: Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961-969, 1994
-
(1994)
Diabetes Care
, vol.17
, pp. 961-969
-
-
Chan, J.M.1
Rimm, E.B.2
Colditz, G.A.3
Stampfer, M.J.4
Willett, W.C.5
-
5
-
-
0030989520
-
Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women: The Nurses' Health Study
-
Carey V, Walters E, Colditz G, Solomon C, Willett W, Rosner B, Speizer F, Manson J: Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women: the Nurses' Health Study. Am J Epidemiol 145:614-619, 1997
-
(1997)
Am J Epidemiol
, vol.145
, pp. 614-619
-
-
Carey, V.1
Walters, E.2
Colditz, G.3
Solomon, C.4
Willett, W.5
Rosner, B.6
Speizer, F.7
Manson, J.8
-
6
-
-
0027062816
-
Abdominal fat distribution and the metabolic syndrome
-
Bjorntorp P: Abdominal fat distribution and the metabolic syndrome. J Cardiovasc Pharmacol 20 (Suppl. 8):S26-S28, 1992
-
(1992)
J Cardiovasc Pharmacol
, vol.20
, Issue.SUPPL. 8
-
-
Bjorntorp, P.1
-
7
-
-
0024587721
-
Biology of regional body fat distribution: Relationship to non-insulin-dependent diabetes mellitus
-
Kissebah AH, Peiris AN: Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 5:83-109, 1989
-
(1989)
Diabetes Metab Rev
, vol.5
, pp. 83-109
-
-
Kissebah, A.H.1
Peiris, A.N.2
-
8
-
-
0027487857
-
Regional obesity and NIDDM
-
Bjorntorp P: Regional obesity and NIDDM. Adv Exp Med Biol 334:279-285, 1993
-
(1993)
Adv Exp Med Biol
, vol.334
, pp. 279-285
-
-
Bjorntorp, P.1
-
9
-
-
0027496056
-
Abdominal obesity as important component of insulin-resistance syndrome
-
Despres J: Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 9:452-459, 1993
-
(1993)
Nutrition
, vol.9
, pp. 452-459
-
-
Despres, J.1
-
10
-
-
0023634861
-
Long-term effects of modest weight loss in type II diabetic patients
-
Wing R, Koeske R, Epstein L, Nowalk M, Gooding W, Becker D: Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 147:1749-1753, 1987
-
(1987)
Arch Intern Med
, vol.147
, pp. 1749-1753
-
-
Wing, R.1
Koeske, R.2
Epstein, L.3
Nowalk, M.4
Gooding, W.5
Becker, D.6
-
11
-
-
0031046184
-
Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team
-
Meigs JB, Singer DE, Sullivan LM, Dukes KA, D'Agostino RB, Nathan DM, Wagner EH, Kaplan SH, Greenfield S: Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): the NIDDM Patient Outcome Research Team. Am J Med 102:38-47, 1997
-
(1997)
Am J Med
, vol.102
, pp. 38-47
-
-
Meigs, J.B.1
Singer, D.E.2
Sullivan, L.M.3
Dukes, K.A.4
D'Agostino, R.B.5
Nathan, D.M.6
Wagner, E.H.7
Kaplan, S.H.8
Greenfield, S.9
-
12
-
-
0025760610
-
Diabetes Intervention Study: Multi-intervention trial in newly diagnosed NIDDM
-
Hanefield M, Fischer S, Schmechel H, Rothe G, Schulze J, Dude H, Schwanebeck U, Julius U: Diabetes Intervention Study: multi-intervention trial in newly diagnosed NIDDM. Diabetes Care 14:308-317, 1991
-
(1991)
Diabetes Care
, vol.14
, pp. 308-317
-
-
Hanefield, M.1
Fischer, S.2
Schmechel, H.3
Rothe, G.4
Schulze, J.5
Dude, H.6
Schwanebeck, U.7
Julius, U.8
-
13
-
-
0028963260
-
Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years
-
United Kingdom Prospective Diabetes Study (UKPDS): 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 310:83-88, 1995
-
(1995)
BMJ
, vol.310
, pp. 83-88
-
-
-
14
-
-
0027482072
-
Short-term medical benefits and adverse effects of weight loss
-
Pi-Sunyer F: Short-term medical benefits and adverse effects of weight loss. Ann Intern Med 119:722-726, 1993
-
(1993)
Ann Intern Med
, vol.119
, pp. 722-726
-
-
Pi-Sunyer, F.1
-
15
-
-
10544235698
-
Long-term pharmacotherapy in the management of obesity
-
National Task Force on the Prevention and Treatment of Obesity: Long-term pharmacotherapy in the management of obesity. JAMA 276:1907-1915, 1996
-
(1996)
JAMA
, vol.276
, pp. 1907-1915
-
-
-
16
-
-
0030867864
-
Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine: A systematic review of the evidence
-
McCann U, Seiden L, Rubin L, Ricaurte G: Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine: a systematic review of the evidence. JAMA 278:666-672, 1997
-
(1997)
JAMA
, vol.278
, pp. 666-672
-
-
McCann, U.1
Seiden, L.2
Rubin, L.3
Ricaurte, G.4
-
17
-
-
0028103894
-
Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers
-
Zhi J, Melia A, Guerciolini R, Chung J, Kinberg J, Hauptman J, Patel I: Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther 56:82-85, 1994
-
(1994)
Clin Pharmacol Ther
, vol.56
, pp. 82-85
-
-
Zhi, J.1
Melia, A.2
Guerciolini, R.3
Chung, J.4
Kinberg, J.5
Hauptman, J.6
Patel, I.7
-
18
-
-
0026604775
-
Initial studies in humans with the novel gas- Trointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin)
-
Hauptman JB, Jeunet FS, Hartmann D: Initial studies in humans with the novel gas- trointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin). Am J Clin Nutr 55 (Suppl. 1):309S-313S, 1992
-
(1992)
Am J Clin Nutr
, vol.55
, Issue.SUPPL. 1
-
-
Hauptman, J.B.1
Jeunet, F.S.2
Hartmann, D.3
-
20
-
-
0028239543
-
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia
-
Tonstad S, Pometta D, Erkelens D, Ose L, Moccetti T, Schouten J, Golay A, Reitsma J, Del Bufalo A, Pasotti E: The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol 46:405-410, 1994
-
(1994)
Eur J Clin Pharmacol
, vol.46
, pp. 405-410
-
-
Tonstad, S.1
Pometta, D.2
Erkelens, D.3
Ose, L.4
Moccetti, T.5
Schouten, J.6
Golay, A.7
Reitsma, J.8
Del Bufalo, A.9
Pasotti, E.10
-
21
-
-
8044234962
-
Metabolic profiles of minimally absorbed orlistat in obese/overweight volunteers
-
Zhi J, Melia A, Funk C, Viger-Chougnet A, Hopfgartner G, Lausecker B, Wang K, Fulton J, Gabriel L, Mulligan T: Metabolic profiles of minimally absorbed orlistat in obese/overweight volunteers. J Clin Pharmacol 36:1006-1011, 1996
-
(1996)
J Clin Pharmacol
, vol.36
, pp. 1006-1011
-
-
Zhi, J.1
Melia, A.2
Funk, C.3
Viger-Chougnet, A.4
Hopfgartner, G.5
Lausecker, B.6
Wang, K.7
Fulton, J.8
Gabriel, L.9
Mulligan, T.10
-
23
-
-
0028817815
-
U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes : A progressive disease
-
U.K. Prospective Diabetes Study Group: U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes : a progressive disease. Diabetes 44:1249-1258, 1995
-
(1995)
Diabetes
, vol.44
, pp. 1249-1258
-
-
-
24
-
-
0023925108
-
Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus
-
Henry RR, Brechtel G, Griver K: Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 66:979-986, 1988
-
(1988)
J Clin Endocrinol Metab
, vol.66
, pp. 979-986
-
-
Henry, R.R.1
Brechtel, G.2
Griver, K.3
-
25
-
-
0027363662
-
Relative effects of calorie restriction and weight loss in non-insulin-dependent diabetes mellitus
-
Kelley DE, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzsimmons M: Relative effects of calorie restriction and weight loss in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77:1287-1293, 1993
-
(1993)
J Clin Endocrinol Metab
, vol.77
, pp. 1287-1293
-
-
Kelley, D.E.1
Wing, R.2
Buonocore, C.3
Sturis, J.4
Polonsky, K.5
Fitzsimmons, M.6
-
26
-
-
0027230221
-
Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease
-
Pontiroli AE, Calderara A, Pacchioni M, Cassisa C, Pozza G: Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease. Diabete Metab 19:30-35, 1993
-
(1993)
Diabete Metab
, vol.19
, pp. 30-35
-
-
Pontiroli, A.E.1
Calderara, A.2
Pacchioni, M.3
Cassisa, C.4
Pozza, G.5
-
27
-
-
0025370045
-
Variables associated with weight loss and improvements in glycemic control in type II diabetic patients in behavioral weight control programs
-
Wing RR, Shoemaker M, Marcus MD, McDermott M, Gooding W: Variables associated with weight loss and improvements in glycemic control in type II diabetic patients in behavioral weight control programs. Int J Obes 14:495-503, 1990
-
(1990)
Int J Obes
, vol.14
, pp. 495-503
-
-
Wing, R.R.1
Shoemaker, M.2
Marcus, M.D.3
McDermott, M.4
Gooding, W.5
-
28
-
-
0025321837
-
Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus
-
Watts N, Spanheimer R, DiGirolamo M, Gebhart S, Musey V, Siddiq Y, Phillips L: Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med 150:803-806, 1990
-
(1990)
Arch Intern Med
, vol.150
, pp. 803-806
-
-
Watts, N.1
Spanheimer, R.2
DiGirolamo, M.3
Gebhart, S.4
Musey, V.5
Siddiq, Y.6
Phillips, L.7
-
29
-
-
0029044690
-
Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM: A placebo-controlled dose-comparison study
-
Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB: Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM: a placebo-controlled dose-comparison study. Diabetes Care 18:817-824, 1995
-
(1995)
Diabetes Care
, vol.18
, pp. 817-824
-
-
Coniff, R.F.1
Shapiro, J.A.2
Robbins, D.3
Kleinfield, R.4
Seaton, T.B.5
Beisswenger, P.6
McGill, J.B.7
-
30
-
-
0029858649
-
A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue
-
Lemieux S, Prudqhomme D, Bouchard C, Tremblay A, Despres J: A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 64:685-693, 1996
-
(1996)
Am J Clin Nutr
, vol.64
, pp. 685-693
-
-
Lemieux, S.1
Prudqhomme, D.2
Bouchard, C.3
Tremblay, A.4
Despres, J.5
-
31
-
-
0029689190
-
Reduction of visceral adipose tissue and improvement in metabolic indices: Effect of dexfenfluramine in NIDDM
-
Marks SJ, Moore NR, Clark ML, Strauss BJG, Hockaday TDR: Reduction of visceral adipose tissue and improvement in metabolic indices: effect of dexfenfluramine in NIDDM. Obes Res 4:1-8, 1996
-
(1996)
Obes Res
, vol.4
, pp. 1-8
-
-
Marks, S.J.1
Moore, N.R.2
Clark, M.L.3
Strauss, B.J.G.4
Hockaday, T.D.R.5
-
32
-
-
3543042129
-
-
FDA Pink Sheet. 9/26/96 FDA's Endocrinologic and Metabolic Drugs Advisory Committee Review of New Drug Application for Sibutramine. Washington, DC, U.S. Govt. Printing Office, Sept. 26, 1996
-
FDA Pink Sheet. 9/26/96 FDA's Endocrinologic and Metabolic Drugs Advisory Committee Review of New Drug Application for Sibutramine. Washington, DC, U.S. Govt. Printing Office, Sept. 26, 1996
-
-
-
|